| Dr Andrea Luise Barry, MD | |
|
103 Newtown Rd, Danbury, CT 06810-4143 | |
| (203) 730-8789 | |
| Not Available |
| Full Name | Dr Andrea Luise Barry |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 21 Years |
| Location | 103 Newtown Rd, Danbury, Connecticut |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1912056649 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 237942 (New York) | Secondary |
| 207V00000X | Obstetrics & Gynecology | 044945 (Connecticut) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Danbury Hospital | Danbury, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Physicians For Women's Health, Llc | 3274430665 | 278 |
News Archive
The complex chain of metabolic events in bacteria that lead to fatal diseases such as tuberculosis (TB) may be better understood using mathematical models, according to an article published in the February issue of Microbiology Today.
Cambridge Research & Instrumentation, Inc. (CRi), a leader in pre-clinical and molecular imaging, announced today that it has signed exclusive agreements to distribute 3DHISTECH's full suite of digital slide scanners and software applications in North America, and the development and distribution of next generation product offerings that address growing applications in digital pathology. These agreements expand CRi's offerings in the rapidly growing digital pathology market.
The U.S. Food and Drug Administration announced today in a Drug Safety Communication that it is requiring an update to the Boxed Warning, the agency's most prominent safety warning, and requiring class-wide labeling changes for benzodiazepines to include the risks of abuse, misuse, addiction, physical dependence and withdrawal reactions to help improve their safe use.
A new report released Wednesday by the U.S. Centers for Disease Control and Prevention (CDC) says that in spite of the widely available screening tests many cancers are not diagnosed until the disease is well-advanced and, therefore, less treatable and more fatal. The report says that half of colorectal cancers and cervical cancers and one-third of breast cancers in the United States are detected at a late stage.
Scientific research into CGM-like sensors goes back more than 40 years. I was working with the first company to begin commercial development, MiniMed, back in 1992 when the science was really beginning to percolate. In 1999 the FDA approved the first CGM device for use in the United States.
› Verified 4 days ago
| Entity Name | Nuvance Health Medical Practice Ct Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407898117 PECOS PAC ID: 4789597691 Enrollment ID: O20031205000130 |
News Archive
The complex chain of metabolic events in bacteria that lead to fatal diseases such as tuberculosis (TB) may be better understood using mathematical models, according to an article published in the February issue of Microbiology Today.
Cambridge Research & Instrumentation, Inc. (CRi), a leader in pre-clinical and molecular imaging, announced today that it has signed exclusive agreements to distribute 3DHISTECH's full suite of digital slide scanners and software applications in North America, and the development and distribution of next generation product offerings that address growing applications in digital pathology. These agreements expand CRi's offerings in the rapidly growing digital pathology market.
The U.S. Food and Drug Administration announced today in a Drug Safety Communication that it is requiring an update to the Boxed Warning, the agency's most prominent safety warning, and requiring class-wide labeling changes for benzodiazepines to include the risks of abuse, misuse, addiction, physical dependence and withdrawal reactions to help improve their safe use.
A new report released Wednesday by the U.S. Centers for Disease Control and Prevention (CDC) says that in spite of the widely available screening tests many cancers are not diagnosed until the disease is well-advanced and, therefore, less treatable and more fatal. The report says that half of colorectal cancers and cervical cancers and one-third of breast cancers in the United States are detected at a late stage.
Scientific research into CGM-like sensors goes back more than 40 years. I was working with the first company to begin commercial development, MiniMed, back in 1992 when the science was really beginning to percolate. In 1999 the FDA approved the first CGM device for use in the United States.
› Verified 4 days ago
| Entity Name | Physicians For Women's Health, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801826680 PECOS PAC ID: 3274430665 Enrollment ID: O20031215000455 |
News Archive
The complex chain of metabolic events in bacteria that lead to fatal diseases such as tuberculosis (TB) may be better understood using mathematical models, according to an article published in the February issue of Microbiology Today.
Cambridge Research & Instrumentation, Inc. (CRi), a leader in pre-clinical and molecular imaging, announced today that it has signed exclusive agreements to distribute 3DHISTECH's full suite of digital slide scanners and software applications in North America, and the development and distribution of next generation product offerings that address growing applications in digital pathology. These agreements expand CRi's offerings in the rapidly growing digital pathology market.
The U.S. Food and Drug Administration announced today in a Drug Safety Communication that it is requiring an update to the Boxed Warning, the agency's most prominent safety warning, and requiring class-wide labeling changes for benzodiazepines to include the risks of abuse, misuse, addiction, physical dependence and withdrawal reactions to help improve their safe use.
A new report released Wednesday by the U.S. Centers for Disease Control and Prevention (CDC) says that in spite of the widely available screening tests many cancers are not diagnosed until the disease is well-advanced and, therefore, less treatable and more fatal. The report says that half of colorectal cancers and cervical cancers and one-third of breast cancers in the United States are detected at a late stage.
Scientific research into CGM-like sensors goes back more than 40 years. I was working with the first company to begin commercial development, MiniMed, back in 1992 when the science was really beginning to percolate. In 1999 the FDA approved the first CGM device for use in the United States.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Andrea Luise Barry, MD 103 Newtown Rd, Danbury, CT 06810-4195 Ph: (203) 730-8789 | Dr Andrea Luise Barry, MD 103 Newtown Rd, Danbury, CT 06810-4143 Ph: (203) 730-8789 |
News Archive
The complex chain of metabolic events in bacteria that lead to fatal diseases such as tuberculosis (TB) may be better understood using mathematical models, according to an article published in the February issue of Microbiology Today.
Cambridge Research & Instrumentation, Inc. (CRi), a leader in pre-clinical and molecular imaging, announced today that it has signed exclusive agreements to distribute 3DHISTECH's full suite of digital slide scanners and software applications in North America, and the development and distribution of next generation product offerings that address growing applications in digital pathology. These agreements expand CRi's offerings in the rapidly growing digital pathology market.
The U.S. Food and Drug Administration announced today in a Drug Safety Communication that it is requiring an update to the Boxed Warning, the agency's most prominent safety warning, and requiring class-wide labeling changes for benzodiazepines to include the risks of abuse, misuse, addiction, physical dependence and withdrawal reactions to help improve their safe use.
A new report released Wednesday by the U.S. Centers for Disease Control and Prevention (CDC) says that in spite of the widely available screening tests many cancers are not diagnosed until the disease is well-advanced and, therefore, less treatable and more fatal. The report says that half of colorectal cancers and cervical cancers and one-third of breast cancers in the United States are detected at a late stage.
Scientific research into CGM-like sensors goes back more than 40 years. I was working with the first company to begin commercial development, MiniMed, back in 1992 when the science was really beginning to percolate. In 1999 the FDA approved the first CGM device for use in the United States.
› Verified 4 days ago
Dr. Nicole Christine Brzozowski, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 24 Hospital Ave, Danbury, CT 06810 Phone: 203-739-6378 | |
Richard S Ruben, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 90 Locust Avenue, Danbury, CT 06810 Phone: 203-792-5005 Fax: 203-791-9899 | |
Yelena Paranyuk, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 90 Locust Ave, Danbury, CT 06810 Phone: 203-792-5005 Fax: 203-791-9899 | |
Patrice S Gillotti, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 90 Locust Avenue, Danbury, CT 06810 Phone: 203-792-5005 Fax: 203-791-9899 | |
Jacqueline Early, Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 24 Hospital Ave Dept Of, Danbury, CT 06810 Phone: 203-739-6378 | |
Pamela J Swift, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 103 Newtown Road, Danbury, CT 06810 Phone: 203-730-8789 Fax: 203-743-5229 | |
Dr. Patricia E Whitcombe, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 27 Hospital Ave, Suite 303, Danbury, CT 06810 Phone: 203-798-0500 Fax: 203-798-0881 |